65,437 trials
Atrial Fibrillation · Venous Thromboembolism · Ischemic Stroke
Primary: Number of Patients With Prothrombin Time Results Within the Therapeutic Range After 2 Weeks — 48; 45 participants
Meningitis · Meningococcal Infection
Primary: Percentage of Participants With Serum Bactericidal Activity of ≥ 1:8 for the Menactra® Meningococcal Serogroups Pre-vaccination, and at 7 Days or 14 Days Post-booster or…
Non-small Cell Lung Cancer
Primary: Best Overall Response — 0; 0; 20; 16 participants
Epilepsy, Partial
Primary: The Percentage of Participants in the 300 mg/Day Dose Group Who Prematurely Discontinued the Study Between Study Visit 5 (Approximately Week 7) and Visit 9 (End of the…
Bunionectomy · Pain · Postoperative Pain
Primary: Sum of Pain Intensity Differences Relative to the Baseline Pain Intensity. — 46.2; 102.5; -17.5 units — p=<0.0001
Head and Neck Cancer · Oral Leukoplakia
Primary: Patients' Overall Response — 0; 15; 2; 4 Participants
Obesity
Primary: Post-drinking Metabolic Rate — 1487 kcal/d
Age Associated Memory Impairment
Primary: Change From Baseline in Rey Auditory Verbal Learning Test — 1.53; 1.00; 5.30; 4.02 number of words correctly recalled
Rhinitis, Allergic, Perennial
Primary: Mean Change From Baseline in Daily rTNSS Over the Entire Treatment Period (28 Days) — -2.10; -2.17 points on a scale — p=0.845
Dyslipidemia
Primary: Maximum Plasma Concentration (Cmax) of Nicotinuric Acid — 1190; 1260 ng/mL
Low Back Pain
Primary: Treatment Responders Based on the Numerical Rating Scale-Pain (NRS-Pain) — 254; 218; 142; 178 participants — p=0.008
Pharmacokinetics
Primary: Maximum Plasma Concentration (Cmax) — 6.84 ng/mL
Contraception
Primary: Number of Participants With Venous Thromboembolism (VTE) — 26; 25 Participants — p=<0.05
Cervical Cancer · Genital Warts
Primary: Incidence of HPV 6/11/16/18-related Cervical Intraepithelial Neoplasia (CIN)(Any Grade), Adenocarcinoma In Situ (AIS) or Cervical Cancer — 0; 1.2 incidence rate per 100…
Pharmacokinetics
Primary: Maximum Serum Concentration (Cmax) — 2450.15; 3553.15 pg/mL